HLA-DRA and myeloid sarcoma: Such mode of targeting was facilitated by a TCRL Ab that is directed towards the highly characterized MS-associated HLA-DR2–restricted MOG35–55 epitope, which was shown to induce severe chronic EAE in HLA-DRA/DRB1*1501-Tg mice (HLA-DR2).